医学
肌萎缩
叙述性评论
肠道菌群
生物信息学
评论文章
内科学
免疫学
炎症
梅德林
系统回顾
益生菌
作者
Minyuan Yang,Tianyu Liu,Qin Yang,Rui Cai,Xiaoqin Yang,Chuandong Tang
标识
DOI:10.1016/j.ajg.2026.03.005
摘要
Sarcopenia, a common and serious complication in patients with liver cirrhosis, is associated with high morbidity and mortality. Accumulating evidence highlights the gut-liver-muscle axis as a key regulatory pathway underlying muscle wasting in cirrhosis, with disruptions in the gut microbiome taking center stage. This review systematically summarizes the mechanisms by which gut microbiota dysregulation contributes to sarcopenia in cirrhosis, examining how compromised intestinal integrity, inflammatory responses, and disrupted metabolism of key compounds, such as short-chain fatty acids, branched-chain amino acids, and bile acids, play pivotal roles in this pathological process. We also critically examine the scientific evidence supporting approaches that target gut microbiome health, aiming to provide a comprehensive and up-to-date overview for clinicians and researchers.
科研通智能强力驱动
Strongly Powered by AbleSci AI